Nissim Benvenisty, MD, PhD
|Prof. Nissim Benvenisty is the Herbert Cohn Chair in Cancer Research and the Director of The Azrieli Center for Stem Cells and Genetic Research at the Hebrew University. He is a member of the Board of Directors of the ISSCR, and serves on the editorial board of various stem cell-related journals. He was awarded several prizes among them the Foulkes Prize (London), the Hestrin Prize, the Teva Prize, the Kaye Prize and the Milken Prize.
Baoyang Hu, PhD
Institute of Zoology, CAS
|Dr. Baoyang Hu is a professor of stem cell and regenerative biology at the Institute of Zoology (IOZ), Chinese academy of Sciences (CAS). He is also the vice director of State Key Laboratory of Stem Cell and Reproductive Biology and the executive dean of medical school at the University of Chinese Academy of Sciences (UCAS). He is interested in transplantable neurons and glia for treating neurological diseases such as Parkinson's diseases and Alzheimer diseases.
Rudolf Jaenisch, MD
Whitehead Institute for Biomedical Research
|Rudolf Jaenisch is a Founding Member of the Whitehead Institute for Biomedical Research and a Professor of Biology at the Massachusetts Institute of Technology. A major technology used in the Jaenisch lab is the gene targeting approach to edit DNA methylation as well as the sequences of target genes in ES cells and in mice. The laboratory is renowned for its expertise in reprogramming cell fate and in studying the myriad factors that contribute to the success and failure of this process. More recently the lab has used iPS cell technology to model human diseases such as Parkinson's, Alzheimer's and Autism. Dr. Jaenisch is a Member of the National Academy of Sciences and the International Society for Stem Cell Research. In 1996 he was honored with the Boehringer Mannheim Molecular Bioanalytics Prize, in 2001 was the recipient of the first ever Peter Gruber Foundation Award in Genetics, in 2002 won the Robert Koch Prize for Excellence in Scientific Achievement and in 2011 was a recipient of the United States National Medal of Science. In 2014 he was president of the ISSCR.
Michael Laflamme, MD, PhD
McEwen Stem Cell Institute, University Health Network
|Dr. Michael Laflamme is the Robert McEwen Chair in Cardiac Regenerative Medicine at University Health Network and a Senior Scientist in the Toronto General Hospital Research Institute. His laboratory is focused on the development of pluripotent stem cell (PSC)-based therapies for ischemic heart disease, and they have show that the transplantation of human PSC-derived cardiomyocytes can partially "remuscularize" the infarct scar with electrically-integrated human myocardium in multiple preclinical models of myocardial infarction.
Wei Li, PhD
Institute of Zoology, CAS
|Wei Li is a principle investigator of Institute of Zoology, Chinese Academy of Sciences. His group is now interested in studying the mechanisms of genome stability of stem cells and cell fate decision, and developing new methods for genome engineering.
Pentao Liu, PhD
Wellcome Trust Sanger Institute
|Dr. Liu graduate from Henan Normal University. He obtained his M.Sc from Chinese Academy of Sciences and Institute of Genetics, and received a Ph.D. from Baylor College of Medicine. Dr. Liu did his postdoc training at National Cancer Institute. He joined the faculty of Wellcome Trust Sanger Institute in 2003 and is currently a Senior Group Leader. Dr. Liu's laboratory is working on stem cells, development, immunity and cancer.
Bennett G. Novitch, PhD
UCLA/Broad Stem Cell Research Center
|Bennett Novitch, M.M.Sc., Ph.D., is the Ethel Scheibel Chair in Neuroscience in the UCLA David Geffen School of Medicine. Dr. Novitch's research seeks to identify how neural tissue is established during fetal development and how neurons form interconnected networks. Dr. Novitch's lab has used brain organoids to better understand how the Zika virus infects and damages fetal brain tissue and identify drugs that may block these devastating effects. Looking ahead, the Novitch lab intends to use these models to study other diseases that affect the formation of the brain or brain circuits such as epilepsy, autism and schizophrenia.
Memorial Sloan Kettering Cancer Center
|Jinghua Piao received her Ph.D in Neuroscience with a focus on Neurodegeneration from the Karolinska Institute. Her PhD and early postdoc work were focused on the role of stem cell transplants in spinal cord injury. She is currently a research associate in the lab of Viviane Tabar at Memorial Sloan Kettering Cancer Center in New York City. She has pursued the use of hES-derived oligodendrocyte progenitors to promote remyelination and rescue cognitive and motor deficits induced by radiation injury to the brain. She is also highly involved in the development of hES derived dopamine neuron grafting strategy for a clinical trial in Parkinson's disease. As a senior research scientist, she leads the in vivo component of this project and contributes to all aspects of the preclinical and regulatory work on the road to the clinic. She is currently working on the derivation of pituitary cells from hES to develop an innovative therapy strategy for pituitary hormone deficiency.
Jose Polo, PhD
|Jose Maria Polo graduated from Buenos Aires University as a Biochemist and obtained his PhD in 2008 at the Albert Einstein College of Medicine, New York under the supervision of Dr. Ari Melnick working on the transcriptional mechanism of BCL6. He then moved to Boston to the laboratory of Dr. Konrad Hochedlinger at the Harvard Stem Cell Institute to work on reprogramming of adult cells into iPS cells. In June 2011, Jose established his independent research group at Monash University to continue his work in reprogramming and epigenetics.
Stephanie Iris Protze, PhD
McEwen Stem Cell Institute
|Dr. Stephanie Protze earned her PhD in Cell Biology and Biomedicine from the International Max Planck Research School at the University of Dresden, Germany in 2012. For her Post Doctoral Fellowship she moved to the laboratory of Dr. Gordon Keller at the McEwen Centre for Regenerative Medicine at the University Health Network in Toronto, Canada during which she has specialized in human heart development and the generation of biological pacemakers using human pluripotent stem cells.
Jeremy Sugarman, MD, MPH, MA
Johns Hopkins University
|Jeremy Sugarman, MD, MPH, MA is the Harvey M. Meyerhoff Professor of Bioethics and Medicine at the Johns Hopkins Berman Institute of Bioethics. He is an internationally recognized leader in the field of biomedical ethics with particular expertise in applying empirical methods for evaluating and analyzing bioethical issues. Dr. Sugarman is a member of ISSCR's Ethics and Public Policy Committees. He is co-chair of the Johns Hopkins' Institutional Stem Cell Research Oversight Committee.
Minoru Takasato, PhD
RIKEN Center for Biosystems Dynamics Research
|Dr Minoru Takasato is a team leader of the laboratory of human organogenesis at RIKEN CDB since 2016, where he heads the kidney regeneration project. He is an expert in the directed differentiation of human pluripotent stem cells to kidney with his most recent work being published in Nature Cell Biology (2014) and Nature (2015). His most recent studies describe the generation of kidney organoids (mini-kidneys) from induced pluripotent stem cells.
Fuchou Tang, PhD
|Dr. Fuchou Tang set up his own lab at BIOPIC, Peking University in 2010 as a principal investigator. His lab focused on studying gene regulation network in human early embryos. His lab systematically developed single cell functional genomics sequencing technologies and used these cutting-edge methods to study the development of human early embryos. He has published more than twenty papers as corresponding authors in Cell, Nature, Science, Cell Stem Cell, Genome Research, Cell Research, etc.
Southwest Hospital, Third Military Medical University
|Zhengqin Yin MD & PhD
Professor and Director of Southwest Eye Hospital, Southwest Hospital, Third Military Medical University , Chongqing, China
Chair of the Key lab of Visual Damage and Regeneration & Restoration in Chongqing
Director of Southwest Eye Bank
Director of Chongqing Institute of Retina
Adjunct Professor of the University of New South Wales, Australia
Honorary Professor and Director of Ophthalmology of General Hospital of PLA, Beijing, China
Cellular therapy for retinal degeneration
Visual development and plasticity,
Xiaoyang Zhao, PhD
Southern Medical University
|Xiao-Yang ZHAO, Ph.D, Professor
He got his Ph.D degree at IOZ, CAS in 2011, and set up a lab in 2011 to study the germ cells development, the application of regenerative medicine in human infertility, focus on somatic reprogramming, transdifferentiation, and germ cell differentiation. He was granted the funding of "National Outstanding Young Scholar" in 2013. In the past few years, He had authored more than 40 SCI papers including Nature, Cell Stem Cell, Nature protocols, Cell Research, JBC and other journals, and also received several awards including the first ISTT Young Investigator Award (2012) and the second prize of "National Natural Science Award" (2014). He had established the first mouse induced pluripotent stem cells (iPSCs) lines which have the competence to produce the "all-iPSC" mice by tetraploid complementation (Nature, 2009), and contributed to establishing the haploid embryonic stem cells (ESCs) which were able to generate alive transgenic adult mice (Nature, 2012), and also contributed to generating the system of complete meiosis from ES-cell derived germ cells in vitro (Cell stem cell).